CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $518,895 | -87.6% | 19,042 | -89.9% | 0.00% | -87.5% |
Q2 2023 | $4,174,679 | +57.8% | 187,626 | +53.6% | 0.01% | +33.3% |
Q1 2023 | $2,645,249 | +251.3% | 122,126 | +315.8% | 0.01% | +200.0% |
Q3 2022 | $753,000 | -42.4% | 29,372 | -46.6% | 0.00% | -33.3% |
Q2 2022 | $1,307,000 | +496.8% | 54,968 | +452.9% | 0.00% | +200.0% |
Q2 2021 | $219,000 | -80.1% | 9,941 | -78.5% | 0.00% | -80.0% |
Q1 2021 | $1,101,000 | -83.3% | 46,278 | -81.6% | 0.01% | -86.1% |
Q4 2020 | $6,577,000 | -31.3% | 251,400 | -54.3% | 0.04% | -41.0% |
Q3 2020 | $9,578,000 | +49.6% | 550,082 | +2.1% | 0.06% | -4.7% |
Q1 2020 | $6,403,000 | +873.1% | 538,555 | +890.4% | 0.06% | +1180.0% |
Q4 2019 | $658,000 | -84.0% | 54,377 | -81.3% | 0.01% | -84.4% |
Q3 2019 | $4,100,000 | +21.2% | 290,186 | -4.4% | 0.03% | +14.3% |
Q2 2019 | $3,384,000 | -43.0% | 303,504 | -40.0% | 0.03% | 0.0% |
Q1 2019 | $5,940,000 | -22.5% | 505,962 | -11.8% | 0.03% | -64.1% |
Q4 2018 | $7,667,000 | +133.2% | 573,836 | +144.7% | 0.08% | +457.1% |
Q3 2018 | $3,288,000 | – | 234,504 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
S&T BANK/PA | 350,924 | $7,601 | 1.37% |
Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |